📰 Authorisation Application News
Authorisation Application News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Authorisation Application. Real-time updates on events, politics, business and more.
November 27, 2023
28.11.2023 - – Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life ...
October 23, 2023
Investegate announcements from Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome
August 11, 2023
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics...
August 10, 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 10, 2023--
August 3, 2023
Synopsis - The Cayman Islands introduced the restructuring offi- cer regime into the Companies Act (as revised) (the ‘Companies Act’) on 31 August 2022. The restructur-...
May 22, 2023
/PRNewswire/ -- BioArctic ABs (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation Application...
May 11, 2023
˗ First quarter 2023 product revenue of $71.4 million; commercial launches of RELYVRIO® in U.S. and ALBRIOZA™ in Canada for the treatment of ALS continue to progress ˗... | May 11, 2023
April 28, 2023
Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...
March 14, 2023
Full year product revenue of $22.2 million; commercial launches of RELYVRIO® in U.S. and ALBRIOZA™ in Canada continue to progressRegulatory review ongoing in the EUKaren Firestone, CEO and co-founder of Aureus Asset Management and prior fund manager at Fidelity Investments, appointed to the Company's Board of Direct...
February 16, 2023
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agencys...